Interestingly, chemo and epigenetic drugs induce PDLIM2-independnet PD-L1 expression on lung cancer and associated macrophages, providing a different mechanism underlying lung cancer resistance to the conventional chemotherapy and potentially new epigenetic therapy. This evidence concerns the gene PDLIM2 and lung cancer.